February 2008

Last Word

January 30, 2008

Michael Naimoli is U.S. Life Sciences Industry Solutions Director for Microsoft, and he has extensive insight into the challenges the industry faces with regard to document regulation and submission management as well as other quality control and business challenges. Before joining Microsoft, Mr. Naimoli spent 11 years in the pharmaceutical and biopharma industries and while […]

Talent Pool

January 30, 2008

Pharma POOL Dr. Michael E. KAMARCK Dr. Michael D. KOWOLENKO Joseph M. MAHADY Cavan M.REDMOND Douglas A. ROGERS Wyeth Hires and Promotes Executives Wyeth, Madison, N.J., has announced a number of executive hires and promotions at its pharmaceuticals and consumer health divisions. At Wyeth Pharmaceu ticals, Collegeville, Pa., Michael E. Kamarck, Ph.D., has been promoted […]

On the Calendar

January 30, 2008

February 19 5th Annual Headache Research Summit Scottsdale,Ariz. For more information, contact National Headache Foundation, via email info@headaches.org, or visit headaches.org. February 1921 Marketing Pharmaceuticals in aTime of Change NewYork Marriott Marquis Hotel,NewYork For more information, contact Ellen Diegel, Drug Information Association, at 2154426158, email ellen.diegel@diahome.org, or visit diahome.org. February 2021 Skin Summit II Park […]

E-Media

January 30, 2008

NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES Octagon Research Solutions Inc. has unveiled ViewPoint for Document Management, a solution that com bines existing Octagon document management, authoring tem plates, and document standards in a preconfigured environment designed to support enterprise authoring processes in the lifesciences industry. ViewPoint for Docu ment Management incor porates document […]

What’s New

January 30, 2008

NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Medical Simulation Corp (MSC) has introduced the SimSuite Collegiate Sales Force Training Program to help organizations provide their salesforces with the clinical competence and cred ibility needed to engage physicians beyond the sales script. The program includes freshman, senior and masterslevel training cours es featuring an instructional curriculum, procedural […]

PharmaTrax

January 30, 2008

Medicare Part D Results in INCREASED USE OF GENERIC DRUGS Generics accounted for more than half the drugs dispensed under Medicare’s Part D in its first six months of availability from January through June 2006. According to Generic Drug Utilization in the Medicare Part D Program, a report from the U.S. Department of Health and […]

PharmaOutlet

January 30, 2008

For what seems like years, I have been attending continuing medical education (CME) meeting after CME meeting, reading article after article, listening to everyone qualified to have an opinion sharing his or her view. The topics and themes have remained the same. Quality improvement (QI) or performance improvement (PI) were the foundation; the theme was […]

HBA Leadership Conference

January 30, 2008

5th Annual HBA Leadership Conference 1 More than 500 industry leaders representing the Healthcare Businesswomen’s Association’s 10 chapters and three affiliates met in Washington,D.C., for an inspirational two?day conference, featuring a distinguished lineup of speakers and sessions. 2 4 7 1. Intrepid members of the HBA hit the streets on a chilly Washington,D.C.,morning to power […]

Developing a Formulary Formula

January 30, 2008

Managed MARKETS Experts on this Topic Sean Brandle. National Rx Practice Leader, The Segal Company, New York; The Segal Company is a private employee-owned actuarial and consulting firm. For more information, visit segalco.com. Larry Olson. VP and Practice Leader, Payer Markets, TNS Healthcare, New York; TNS Healthcare provides market research consulting and custom advisory services […]

Managing Investigator Initiated Trials

January 30, 2008

Investigator initiated trials (IITs) can be a valuable part of a pharmaceutical or medical device manufacturer’s marketing claims arsenal, according to Rita Numerof, Ph.D., president, and Mark Morgan, M.S., senior business analyst, at Numerof & Associates Inc. The two contend that IITs are relatively low cost because much of the up front work is performed […]

Conquering the Divide — Joseph Pieroni

January 30, 2008

BY KIM RIBBINK Drawn initially to the lab as a medicinal chemist,then to the business side of pharma research, Joseph P. Pieroni has been able to straddle the often divided worlds of research and marketing seamlessly. This combination of skills and interests is great news for Daiichi Sankyo Inc., the U.S. subsidiary of Daiichi Sankyo […]

Super Bugs

January 30, 2008

Bacteria have proven to be resourceful organisms. They are so resourceful that the widespread use of antibiotics in recent years has enabled bacteria to adapt and develop resistance to currently marketed treatments. Antibiotics stop infection and the spread of infection, yet they also eventually decrease in effective ness because of mutations of the pathogen. In […]

MSLs: Evolution of Skills

January 30, 2008

The intent of the first MSL role, created in 1967 by the Upjohn Company, was to create a position within the pharmaceutical company that could interact with academiabased physicians and researchers. In the 1970s, the trend grew, with other companies mostly implementing MSL hir ing from within their own sales organizations. According to attorney Mark […]

Gene Therapy Research Makes Progress

January 29, 2008

With all the progress that has been made in genomics, targeting therapies to correct the defective genes responsible for disease seems quite realistic. But developing commercial gene therapies to treat diseases through modifying the expressions of an individual’s genes or correcting abnormal genes has proven to be more difficult. While hundreds of treatments that involve […]

Controlling the Message in Cyber Space and Time

January 29, 2008

Keeping Up With the 2.0 Joneses To maintain a competitive edge in today’s crowded environment,most experts believe the industry needs to step up its 2.0 practices or get left behind in a swirl of networking dust. Not only may early adopters get a marketing leg up on companies that choose to drag their heels, but […]

UpFront

January 29, 2008

THE PRICE IS RIGHT Drug Pricing Decisions More Critical Than Ever In aneraofmore competition from generics, expiring patent protection for many topselling drugs, and a slowdown in new drug discoveries, there is very little margin for error in drug pricing decisions. Kalorama Information’s recent report states that pharma sales reached $643 billion worldwide in 2006, […]

Letter from the Editor

January 29, 2008

Wh o w o u l d h a v e thought that in 10 short years, we would have gone from Dolly to Elsie? In February 1997, scientists in Scotland announced the birth of the world’s first successfully cloned mammal, Dolly the sheep. Dolly, which was created at the Roslin Institute in Edinburgh, was […]

FEEDBACK